Used primarily in pharmaceutical research, this compound serves as a key intermediate in the synthesis of bioactive molecules. Its chiral structure makes it valuable in the development of enantiomerically pure drugs, particularly those targeting neurological disorders. The trifluoromethoxy group enhances metabolic stability and bioavailability, making it suitable for drug candidates requiring prolonged activity. It is also explored in the design of compounds for potential antidepressant or anxiolytic applications due to its amine functionality, which interacts with neurotransmitter systems. Additionally, its hydrochloride form improves solubility, facilitating its use in experimental formulations and preclinical studies.